Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Current Assets: 2018-2024

Historic Current Assets for Neurogene (NGNE) over the last 4 years, with Dec 2024 value amounting to $315.9 million.

  • Neurogene's Current Assets rose 88.32% to $270.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.5 million, marking a year-over-year increase of 88.32%. This contributed to the annual value of $315.9 million for FY2024, which is 57.69% up from last year.
  • Per Neurogene's latest filing, its Current Assets stood at $315.9 million for FY2024, which was up 57.69% from $200.3 million recorded in FY2023.
  • Neurogene's Current Assets' 5-year high stood at $315.9 million during FY2024, with a 5-year trough of $200.3 million in FY2023.
  • Its 2-year average for Current Assets is $258.1 million, with a median of $258.1 million in 2023.
  • Data for Neurogene's Current Assets shows a peak YoY spiked of 57.69% (in 2024) over the last 5 years.
  • Over the past 2 years, Neurogene's Current Assets (Yearly) stood at $200.3 million in 2023, then soared by 57.69% to $315.9 million in 2024.